| A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2 S Yang, P He, J Wang, A Schetter, W Tang, N Funamizu, K Yanaga, ... Cancer research 76 (13), 3838-3850, 2016 | 270 | 2016 |
| MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 S Yang, Y Li, J Gao, T Zhang, S Li, A Luo, H Chen, F Ding, X Wang, Z Liu Oncogene 32 (36), 4294-4303, 2013 | 257 | 2013 |
| Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation H Chen, Y Yuan, C Zhang, A Luo, F Ding, J Ma, S Yang, Y Tian, T Tong, ... Journal of Biological Chemistry 287 (21), 17109-17119, 2012 | 90 | 2012 |
| Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming Y Wang, Y Chen, L Guan, H Zhang, Y Huang, CH Johnson, Z Wu, ... Cell Death & Differentiation 25 (4), 735-748, 2018 | 69 | 2018 |
| Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer J Wang, P He, M Gaida, S Yang, AJ Schetter, J Gaedcke, BM Ghadimi, ... Oncotarget 7 (33), 52993, 2016 | 51 | 2016 |
| Endothelial nitric oxide synthase traffic inducer (NOSTRIN) is a negative regulator of disease aggressiveness in pancreatic cancer J Wang, S Yang, P He, AJ Schetter, J Gaedcke, BM Ghadimi, T Ried, ... Clinical cancer research 22 (24), 5992-6001, 2016 | 39 | 2016 |
| Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro S Yang, JJ Liu, Y Chen, J Jiang Biomedicine & Pharmacotherapy 66 (3), 187-194, 2012 | 31 | 2012 |
| NO•/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer L Wang, W Tang, S Yang, P He, J Wang, J Gaedcke, P Ströbel, A Azizian, ... International journal of cancer 146 (11), 3160-3169, 2020 | 30 | 2020 |
| Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients S Yang, W Tang, A Azizian, J Gaedcke, P Ströbel, L Wang, H Cawley, ... Carcinogenesis 43 (12), 1198-1210, 2022 | 17 | 2022 |
| SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer Y Ohara, W Tang, H Liu, S Yang, TH Dorsey, H Cawley, P Moreno, ... Cell reports 42 (12), 2023 | 6 | 2023 |
| ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer Y Ohara, H Liu, AJ Craig, S Yang, P Moreno, TH Dorsey, H Cawley, ... International Journal of Cancer, 2024 | 1 | 2024 |
| LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism Y Ohara, AJ Craig, H Liu, S Yang, P Moreno, TH Dorsey, H Cawley, ... Carcinogenesis, bgae011, 2024 | 1 | 2024 |
| Nitric oxide signaling pathway as a pathogenic driver in pancreatic cancer J Wang, P He, MM Gaida, S Yang, A Schetter, J Gaedcke, M Ghadimi, ... Cancer Research 75 (15_Supplement), 923-923, 2015 | 1 | 2015 |
| Macrophage migration inhibitory factor (MIF) and miR-301b interactively enhance disease aggressiveness by targeting NR3C2 in human pancreatic cancer S Yang, P He, J Wang, A Schetter, N Funamizu, K Yanaga, J Gaedcke, ... Cancer Research 74 (19_Supplement), 4363-4363, 2014 | 1 | 2014 |
| MIF/NR3C2 axis regulates glucose metabolism reprogramming in pancreatic cancer through MAPK–ERK and AP-1 pathways S Yang, W Tang, A Azizian, J Gaedcke, Y Ohara, H Cawley, N Hanna, ... Carcinogenesis, bgae025, 2024 | | 2024 |
| SERPINB3 induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer Y Ohara, W Tang, H Liu, S Yang, TH Dorsey, H Cawley, P Moreno, ... bioRxiv, 2023.03. 29.534766, 2023 | | 2023 |
| LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism Y Ohara, AJ Craig, H Liu, S Yang, P Moreno, TH Dorsey, H Cawley, ... bioRxiv, 2023.11. 01.564448, 2023 | | 2023 |
| A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2 S Yang, P He, L Wang, J Wang, A Schetter, W Tang, N Funamizu, ... Cancer Research 77 (13_Supplement), 4789-4789, 2017 | | 2017 |
| Macrophage migration inhibitory factor (MIF) and miR-301b interactively enhance disease aggressiveness by targeting NR3C2 (nuclear receptor subfamily group c member 2) in human … S Yang, P He, J Wang, A Schetter, W Tang, N Funamizu, J Gaedcke, ... Cancer Research 75 (15_Supplement), 922-922, 2015 | | 2015 |
| Nitric oxide enhances tumor progression and disease aggressiveness in pancreatic cancer J Wang, P He, MM Gaida, S Yang, A Schetter, J Gaedcke, M Ghadimi, ... Cancer Research 74 (19_Supplement), 926-926, 2014 | | 2014 |
